Pure Global

ORTHO-CLINICAL DIAGNOSTICS COLOMBIA S.A.S - Authorized Company ProfileORTHO-CLINICAL DIAGNOSTICS COLOMBIA S.A.S

Explore comprehensive authorized company profile for ORTHO-CLINICAL DIAGNOSTICS COLOMBIA S.A.S through Pure Global AI's free Colombia medical device database. This company manufactures 66 medical devices registered with INVIMA across 5 risk classes. Their registration history spans from Feb 25, 2024 to Apr 29, 2034.

This page provides detailed insights including recent registrations, risk class distribution (II: 29, IIa: 8, III: 20, and more), and complete regulatory information from the official Colombia INVIMA medical device database with bilingual Spanish/English support. Pure Global AI offers free access to Colombia's complete medical device registry.

Free Authorized Company Profile
Powered by Pure Global AI
66 Devices
5 Risk Classes
ORTHO-CLINICAL DIAGNOSTICS COLOMBIA S.A.S
ORTHO-CLINICAL DIAGNOSTICS COLOMBIA S.A.S
Authorized Company
66
Total Devices
5
Risk Classes
2024
Earliest
2034
Latest
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Recent Registrations
Latest 20 INVIMA device registrations

VITROS INMUNODIAGNOSTIC PRODUCTS INTACT PTH II REAGENT PACK

VITROS INMUNODIAGNOSTIC PRODUCTS INTACT PTH II REAGENT PACK

d9a3fcbeb2eae6a7d4d022b7880682e5

II
Apr 29, 2034

ESTACIÓN DE TRABAJO DE SOBREMESA PARA INCUBACIÓN Y CENTRIFUGACIÓN - ORTHO WORKSTATION

BENCHTOP INCUBATION & CENTRIFUGE WORKSTATION - ORTHO WORKSTATION

8e3ff6941df3dde39910be1abf9be70a

I
Apr 15, 2034

QUIDEL TRIAGE® CARDIO2 PANEL

QUIDEL TRIAGE® CARDIO2 PANEL

45229f74414086470dcac0dbac9c1f88

II
Apr 02, 2034

QUIDEL TRIAGE® NT-PROBNP TEST

QUIDEL TRIAGE® NT-PROBNP TEST

19db858aad5fdd4b8d983348ce776a9d

II
Apr 02, 2034

QUIDEL TRIAGETRUE™ HIGH SENSITIVITY TROPONIN I TEST

QUIDEL TRIAGETRUE™ HIGH SENSITIVITY TROPONIN I TEST

1ede6f7e5bb2c890f2a01dbf1f546eb5

II
Feb 05, 2034

1. VITROS LMMUNODIAGNOSTIC PRODUCTS TOTAL T3 II REAGENT PACK

1. VITROS LMMUNODIAGNOSTIC PRODUCTS TOTAL T3 II REAGENT PACK

bf270d887ad16314ad8eba96564f0d6f

II
Nov 14, 2033

SOFIA® STREP A+ FIA

SOFIA STREP A+ FIA®

8f3200f321a881bc7fe22c2c339bfd7b

II
Aug 15, 2033

SOFIA® RSV FIA

SOFIA RSV FIA®

3c5573fddc530b8a19dfc61b4ea56c08

II
Aug 11, 2033

VITROS IMMUNODIAGNOSTIC PRODUCTS IL-6 CONTROLS

VITROS IMMUNODIAGNOSTIC PRODUCTS IL-6 CONTROLS

428f988b2ca8723feda0f506fe8ba9b2

Nov 30, 2031

VITROS IMMUNODIAGNOSTIC PRODUCTS IL-6 CALIBRATORS

VITROS IMMUNODIAGNOSTIC PRODUCTS IL-6 CALIBRATORS

e41c8363896e3b7720f115f26645de59

Nov 30, 2031

VITROS IMMUNODIAGNOSTIC PRODUCTS IL-6 REAGENT PACK

VITROS IMMUNODIAGNOSTIC PRODUCTS IL-6 REAGENT PACK

3070c400a12a983641706d43707ee8ec

II
Nov 30, 2031

TRIAGEPLGF

TRIAGEPLGF

85c173ce4207e320fd984515fc76b648

II
Jul 28, 2031

VITROS XT CHEMISTRY PRODUCTS TRIG-CHOL SLIDES

VITROS XT CHEMISTRY PRODUCTS TRIG-CHOL SLIDES

7056d625bdea79ccded97074f13d0558

Apr 30, 2031

VITROS XT CHEMISTRY PRODUCTS ALB-TP SLIDES

VITROS XT CHEMISTRY PRODUCTS ALB-TP SLIDES

31beb19d3416a5c504e0d2d54ec96062

Apr 30, 2031

VITROS XT CHEMISTRY PRODUCTS TBIL-ALKP SLIDES

VITROS XT CHEMISTRY PRODUCTS TBIL-ALKP SLIDES

c604c0a85cc8ff0e307672fba8af0cfc

Apr 30, 2031

VITROS XT CHEMISTRY PRODUCTS ALTV-AST SLIDES

VITROS XT CHEMISTRY PRODUCTS ALTV-AST SLIDES

613841d57da0d9641705496d7d836b0a

II
Apr 30, 2031

VITROS XT CHEMISTRY PRODUCTS GLU-CA SLIDES

VITROS XT CHEMISTRY PRODUCTS GLU-CA SLIDES

fa38d71e32e0f1dfe848354bc0fc360d

Apr 30, 2031

VITROS IMMUNODIAGNOSTIC PRODUCTS TSH3 REAGENT PACK

VITROS IMMUNODIAGNOSTIC PRODUCTS TSH3 REAGENT PACK

8690954fdf2c0b2a0e85916c51905a09

II
Apr 07, 2031

VITROS IMMUNODIAGNOSTIC PRODUCTS TSH3 CALIBRATORS

VITROS IMMUNODIAGNOSTIC PRODUCTS TSH3 CALIBRATORS

d2f3639eb81bbb5039d3d4290713bd27

Apr 07, 2031

QUIDEL TRIAGE TOX DRUG SCREEN, 94600

QUIDEL TRIAGE TOX DRUG SCREEN, 94600

f1236b963fd345b809751a1bdc5f57b3

II
Feb 15, 2031
Risk Class Distribution
Devices by risk class
II
29
43.9% of total
III
20
30.3% of total
IIa
8
12.1% of total
Unspecified
7
10.6% of total
I
2
3.0% of total